Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.2K Buy
1,600
+1,400
+700% +$74K ﹤0.01% 419
2026
Q1
$9.46K Hold
200
﹤0.01% 469
2025
Q4
$8.38K Buy
200
+17
+9% +$793 ﹤0.01% 467
2025
Q3
$7.29K Hold
183
﹤0.01% 461
2025
Q2
$7.06K Hold
183
﹤0.01% 471
2025
Q1
$7.09K Hold
183
﹤0.01% 489
2024
Q4
$6.16K Buy
+183
New +$6.59K ﹤0.01% 547

Other funds holding GSK

Union Bancaire Privee's GSK Position: Q2 2026 in Review

Union Bancaire Privee increased its GSK (GSK) stake by 700% in Q2 2026, buying an estimated $74K and bringing the position to 1,600 shares worth $83.2K. The position accounts for ﹤0.01% of the portfolio, ranked #419.

Union Bancaire Privee first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. 161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Union Bancaire Privee held 1,600 shares of GSK worth $83.2K as of Q2 2026.
  • Union Bancaire Privee bought 1,400 GSK shares in Q2 2026, an estimated $74K.
  • GSK made up ﹤0.01% of Union Bancaire Privee's portfolio in Q2 2026, its #419 holding.
  • Union Bancaire Privee first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • 161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.